Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The skills and strategies you developed during month one become even more valuable as dosing increases
Winners will be biotechs and products that deliver: Systemic metabolic platforms Therapies combining fat loss with muscle preservation Long-term maintenance and relapse-prevention solutions Adherence, formulation, and delivery innovations Losers will be biotechs or products characterized by: Mono-organ, late-stage interventions Products without meaningful weight or metabolic impact Incremental add-ons justified by biomarker shifts alone Startups at Strategic Risk in the Post-GLP-1++ Era Retatrutide does not merely compete with other drugs it raises the minimum threshold of relevance
PMID: 17 BassotA.ChenJ.Takahashi-YamashiroK.YapM
We have witnessed improved joint mobility in patients using GLP-1 therapy, offering a comprehensive approach to managing joint pain alongside other metabolic benefits
Additionally, GLP-1 receptors are present in the enteric nervous system the network of nerves governing gut function and activation here may independently influence peristalsis (the wave-like muscle contractions that move contents through the bowel)
On communication, GLP-1 users are more intentional label readers than the average consumer messaging that aligns with their health priorities will build the trust that this cohort responds to
